Mouse development is not obviously affected by the absence of dermatan sulfate epimerase 2 in spite of a modified brain dermatan sulfate composition

Glycobiology

Volumn 22, Issue 7, 2012, Pages 1007-1016

  Bartolini, Barbara ^a   Thelin, Martin A ^a   Rauch, Uwe ^a   Feinstein, Ricardo ^b   Oldberg, Ke ^a   Malmström, Anders ^a   MacCarana, Marco ^a  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

Brain extracellular matrix; Dermatan sulfate; Dermatan sulfate epimerase 1 2; Iduronic acid

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE DERIVATIVE; DERMATAN SULFATE EPIMERASE 2; DOPAMINE 4 SULFATE; IDURONIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; IMMUNOHISTOLOGY; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; CARBOHYDRATE CONFORMATION; CARBOHYDRATE EPIMERASES; CELLS, CULTURED; DERMATAN SULFATE; DISACCHARIDES; EXTRACELLULAR MATRIX; FEMALE; GENE KNOCKOUT TECHNIQUES; IDURONIC ACID; KIDNEY; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; SULFATES;

MUS;

EID: 84861416926     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws065     Document Type: Article

References (37)

1. Akatsu C, Mizumoto S, Kaneiwa T, Maccarana M, Malmstrom A, Yamada S, Sugahara K. 2011. Dermatan sulfate epimerase 2 is the predominant isozyme in the formation of the chondroitin sulfate/dermatan sulfate hybrid structure in postnatal developing mouse brain. Glycobiology. 21:565-574.
2. Bao X, Nishimura S, Mikami T, Yamada S, Itoh N, Sugahara K. 2004. Chondroitin sulfate/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of L-iduronic acid than those from adult pig brain, exhibit neuritogenic and growth factor binding activities. J Biol Chem. 279:9765-9776. (Pubitemid 38372574)
3. Cichon S, Muhleisen TW, Degenhardt FA, Mattheisen M, Miro X, Strohmaier J, Steffens M, Meesters C, Herms S, Weingarten M, et al. 2011. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet. 88:372-381.
4. Coles CH, Shen Y, Tenney AP, Siebold C, Sutton GC, Lu W, Gallagher JT, Jones EY, Flanagan JG, Aricescu AR. 2011. Proteoglycan-specific molecular switch for RPTPsigma clustering and neuronal extension. Science. 332:484-488.
5. Dundar M, Muller T, Zhang Q, Pan J, Steinmann B, Vodopiutz J, Gruber R, Sonoda T, Krabichler B, Utermann G, et al. 2009. Loss of dermatan-4- sulfotransferase 1 function results in adducted thumb-clubfoot syndrome. Am J Hum Genet. 85:873-882.
6. Giamanco KA, Morawski M, Matthews RT. 2010. Perineuronal net formation and structure in aggrecan knockout mice. Neuroscience. 170:1314-1327.
7. Gilbert RJ, McKeon RJ, Darr A, Calabro A, Hascall VC, Bellamkonda RV. 2005. CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol Cell Neurosci. 29:545-558. (Pubitemid 40984696)
8. Goossens D, Van Gestel S, Claes S, De Rijk P, Souery D, Massat I, Van den Bossche D, Backhovens H, Mendlewicz J, Van Broeckhoven C, et al. 2003. A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder. Mol Psychiatry. 8:83-89. (Pubitemid 36188576)
9. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. 2005. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu Rev Biochem. 74:385-410. (Pubitemid 40995512)
10. Hikino M, Mikami T, Faissner A, Vilela-Silva AC, Pavao MS, Sugahara K. 2003. Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: Implications of dermatan sulfate in neuritogenesis in the brain. J Biol Chem. 278:43744-43754. (Pubitemid 37346002)
11. Holst CR, Bou-Reslan H, Gore BB, Wong K, Grant D, Chalasani S, Carano RA, Frantz GD, Tessier-Lavigne M, Bolon B, et al. 2007. Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS One. 2:e575.
12. Jia J, Maccarana M, Zhang X, Bespalov M, Lindahl U, Li JP. 2009. Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J Biol Chem. 284:15942-15950.
13. Kantor DB, Chivatakarn O, Peer KL, Oster SF, Inatani M, Hansen MJ, Flanagan JG, Yamaguchi Y, Sretavan DW, Giger RJ, et al. 2004. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron. 44:961-975. (Pubitemid 39643092)
14. Kreuger J, Spillmann D, Li JP, Lindahl U. 2006. Interactions between heparan sulfate and proteins: The concept of specificity. J Cell Biol. 174:323-327. (Pubitemid 44156762)
15. Kusche-Gullberg M, Kjellen L. 2003. Sulfotransferases in glycosaminoglycan biosynthesis. Curr Opin Struct Biol. 13:605-611. (Pubitemid 37244116)
16. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, Zhang X, Lindahl U. 2003. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem. 278:28363-28366. (Pubitemid 36935735)
17. Li F, Nandini CD, Hattori T, Bao X, Murayama D, Nakamura T, Fukushima N, Sugahara K. 2010. Structure of pleiotrophin-and hepatocyte growth factor-binding sulfated hexasaccharide determined by biochemical and computational approaches. J Biol Chem. 285:27673-27685.
18. Maccarana M, Kalamajski S, Kongsgaard M, Magnusson SP, Oldberg A, Malmstrom A. 2009. Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin. Mol Cell Biol. 29:5517-5528.
19. Maccarana M, Olander B, Malmstrom J, Tiedemann K, Aebersold R, Lindahl U, Li JP, Malmstrom A. 2006. Biosynthesis of dermatan sulfate: Chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem. 281:11560-11568. (Pubitemid 43855412)
20. Malmstrom A, Fransson LA. 1975. Biosynthesis of dermatan sulfate. I. Formation of L-iduronic acid residues. J Biol Chem. 250:3419-3425.
21. Mitsunaga C, Mikami T, Mizumoto S, Fukuda J, Sugahara K. 2006. Chondroitin sulfate/dermatan sulfate hybrid chains in the development of cerebellum. Spatiotemporal regulation of the expression of critical disulfated disaccharides by specific sulfotransferases. J Biol Chem. 281:18942-18952. (Pubitemid 44035397)
22. Nakao M, Shichijo S, Imaizumi T, Inoue Y, Matsunaga K, Yamada A, Kikuchi M, Tsuda N, Ohta K, Takamori S, et al. 2000. Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL. J Immunol. 164:2565-2574. (Pubitemid 30115487)
23. Nandini CD, Sugahara K. 2006. Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors. Adv Pharmacol. 53:253-279.
24. Pacheco B, Malmstrom A, Maccarana M. 2009. Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate. J Biol Chem. 284:9788-9795.
25. Properzi F, Carulli D, Asher RA, Muir E, Camargo LM, van Kuppevelt TH, ten Dam GB, Furukawa Y, Mikami T, Sugahara K, et al. 2005. Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur J Neurosci. 21:378-390. (Pubitemid 40204241)
26. Purushothaman A, Sugahara K, Faissner A. 2012. Chondroitin sulfate "wobble motifs" modulate maintenance and differentiation of neural stem cells and their progeny. J Biol Chem. 287:2935-2942.
27. Radek KA, Taylor KR, Gallo RL. 2009. FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation. Wound Repair Regen. 17:118-126.
28. Rauch U. 2007. Brain matrix: Structure, turnover and necessity. Biochem Soc Trans. 35:656-660. (Pubitemid 47310334)
29. Rauch U, Kappler J. 2006. Chondroitin/dermatan sulfates in the central nervous system: Their structures and functions in health and disease. Adv Pharmacol. 53:337-356.
30. Seidler DG, Breuer E, Grande-Allen KJ, Hascall VC, Kresse H. 2002. Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans. J Biol Chem. 277:42409-42416. (Pubitemid 35264601)
31. Shively JE, Conrad HE. 1976. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry. 15:3932-3942.
32. Silbert JE, Sugumaran G. 2002. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life. 54:177-186. (Pubitemid 36008326)
33. Sugahara K, Mikami T. 2007. Chondroitin/dermatan sulfate in the central nervous system. Curr Opin Struct Biol. 17:536-545. (Pubitemid 350019013)
34. Taylor KR, Rudisill JA, Gallo RL. 2005. Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. J Biol Chem. 280:5300-5306. (Pubitemid 40280003)
35. Tiedemann K, Larsson T, Heinegard D, Malmstrom A. 2001. The glucuronyl C5-epimerase activity is the limiting factor in the dermatan sulfate biosynthesis. Arch Biochem Biophys. 391:65-71. (Pubitemid 32618702)
36. Trowbridge JM, Gallo RL. 2002. Dermatan sulfate: New functions from an old glycosaminoglycan. Glycobiology. 12:117R-125R.
37. Yamada S, Sugahara K. 2008. Potential therapeutic application of chondroitin sulfate/dermatan sulfate. Curr Drug Discov Technol. 5:289-301.